Report Basic Information - Reported Company: Jilin Aodong [16] - Industry: Chemical Pharmaceuticals [2] - Research Date: July 17, 2025 [16] - Company Representatives: Wang Zhenyu (Director, Deputy General Manager, Secretary of the Board), Zhao Renhe (Director of the Board Office, Securities Affairs Representative) [16] Participating Institutions - "Innovation Sailing, King's Moment - The 20th Pharmaceutical Hundred Listed Companies Exchange Meeting (Beijing Station)" [17] - Guosheng Securities (Representative: Zhang Yu) [17] - Beijing Hongdao (Representative: Tang Yulin) [17] - Yimin Fund (Representative: Gui Guan) [17] - CITIC Securities Asset Management (Representative: Peng Kang) [17] - Ginkgo Capital (Representative: Zhang Haijun) [17] Institution Proportion - Others: 33% [21] - Securities Companies: 17% [21] - Investment Companies: 17% [21] - Fund Management Companies: 17% [21] - Asset Management Companies: 17% [21] Core Business Highlights Business Revenue Structure in 2024 - Total revenue from three major business segments (traditional Chinese medicine, chemical drugs, and chain pharmacy wholesale and retail) reached 2.273761 billion yuan, with traditional Chinese medicine contributing 1.6055413 billion yuan (61.50%), chemical drugs 276.8538 million yuan (10.61%), and chain pharmacy business 391.366 million yuan (14.99%) [22] - Revenue from the health - care business was 212.1299 million yuan, accounting for 8.13% of the total revenue [22] Key Product Analysis - **An Shen Bu Nao Ye**: With a large target audience due to the increasing number of insomnia sufferers, its sales growth is supported by consumer trust in the brand and product efficacy, and the unique geographical advantage of its raw materials. It is mainly sold outside hospitals. The company implements an "An Shen +" combination strategy to drive performance growth [22][23] - **Xue Fu Zhu Yu Kou Fu Ye**: A well - recognized product with multiple honors. Its selection in the national Chinese patent medicine procurement alliance's volume - based procurement in 2024 is expected to expand sales. The company will continue brand building, strengthen cooperation with major pharmaceutical chains, and promote clinical use [24] Project Progress - **Chinese Medicine Formula Granule Project**: As of December 31, 2024, 228.776 million yuan of the raised funds had been used. Multiple workshops passed the GMP compliance inspection on January 23, 2025. The company has obtained 525 "Listing Filing Certificates for Chinese Medicine Formula Granules" and is focusing on market development [25] Investment in GF Securities - As of March 31, 2025, the company and its wholly - owned subsidiaries held 1,529,911,767 shares of GF Securities, accounting for 20.11% of the total shares. In 2024, the company's investment income from GF Securities was 174.94045 million yuan, a 40.69% increase from the previous year [25][26] Dividend Policy - The company has formulated a "Three - Year (2024 - 2026) Shareholder Return Plan", increasing the frequency and optimizing the rhythm of dividends. It has a 17 - year history of cash dividends, with a cumulative cash dividend of 4.505 billion yuan since listing. It aims to enhance the stability and predictability of dividends in the future [26]

Investment Rating - The industry investment rating is "Buy" [2] Core Insights - The recent trade agreement between the US and Vietnam is favorable for Chinese manufacturers with production capacity in Vietnam, such as Ruiming Technology and Daotong Technology. This agreement clarifies tariff situations, allowing these companies to benefit from lower tariffs when exporting to the US [6] - Ruiming Technology has invested in a smart manufacturing center in Vietnam since 2022, which began production in May 2023. The company estimates that the US market will account for nearly 15% of its total revenue in Q1 2025, supported by strong bargaining power due to high product technology content and deep customer ties [6] - Daotong Technology has diversified its production capacity, which will mitigate the impact of tariffs. The company has established an SMT production line in Vietnam since 2020 and aims for 50% of its total revenue to come from the US by 2024. The company is also expanding its presence in Mexico, benefiting from zero-tariff advantages under the US-Mexico-Canada Agreement [6] Summary by Sections Trade Agreement Impact - The US-Vietnam trade agreement imposes a 20% tariff on goods imported from Vietnam to the US, while Vietnam will exempt US imports. Products from other countries transiting through Vietnam will face a 40% tariff [6] - This agreement is expected to benefit companies like Ruiming Technology and Daotong Technology, which have established production facilities in Vietnam [6] Company Performance - Ruiming Technology's high product technology content and strong customer relationships enhance its pricing power, leading to high gross margins and potential profit growth [6] - Daotong Technology's AI initiatives and diversified production strategies are expected to drive further performance improvements [6] Financial Analysis - Ruiming Technology's estimated EPS for 2025 is 2.41 CNY, with a PE ratio of 20.37x, while Daotong Technology's estimated EPS is 1.79 CNY, with a PE ratio of 17.88x [7]

Employment Data Summary - In June, the U.S. added 147,000 non-farm jobs, exceeding the expected 106,000[3] - The unemployment rate fell to 4.1%, lower than the expected 4.3% and previous value of 4.2%[3] - The average increase in non-farm jobs over the past three months is 150,000[3] Sector Analysis - Private sector job growth was 74,000, below the expected 100,000[3] - State and local government sectors added 80,000 jobs, with healthcare contributing 59,000 and leisure and hospitality adding 20,000, accounting for 96% of total job growth[3] - Manufacturing, wholesale trade, and federal government sectors each lost 7,000 jobs, indicating weaknesses in these areas[4] Unemployment Insights - The unemployment rate (U3) decreased from 4.24% to 4.12%, with the permanent unemployment rate dropping from 1.12% to 1.11%[4] - Initial jobless claims fell by 4,000 to 233,000, while continuing claims remained steady at 1.964 million[4] Labor Market Dynamics - The labor force participation rate was 62.3%, slightly below the expected 62.4%[7] - Job leavers contributed 0.07 percentage points to the unemployment rate, while other factors negatively impacted it[6] - The employment diffusion index fell below 50 for the second time since August 2024, indicating a slowdown in job growth[6] Wage Growth Trends - Average hourly earnings increased by 3.7% year-over-year, slightly below the expected 3.8%[7] - The Index of Aggregate Payrolls Private showed a year-over-year increase of 4.5%, down from 4.9% but still above the average of 4.8% for 2024[8] Federal Reserve Outlook - The likelihood of the Federal Reserve not lowering interest rates in July is high, with a 63.8% probability of a rate cut in September[8] - Strong employment data and policy stimulus have alleviated concerns about economic downturns, supporting risk assets[8]

Core Insights - The report highlights the acceleration of deep-sea wind power development in China, with a significant increase in both onshore and offshore wind installations expected in 2025, projecting 100GW for onshore and 15GW for offshore [5][15][19] - The transition from a "price war" to a "value war" in the wind turbine market is noted, emphasizing the importance of technology development and cost control to achieve a reasonable price recovery for equipment [5][15] - The global wind power market is expected to add 170GW in new installations in 2025, with China contributing 115GW, reflecting a year-on-year growth of 32.20% [5][15] Policy Support and Market Dynamics - Domestic policies are driving the rapid development of offshore wind power, with various provinces setting ambitious targets for wind energy installations under the 14th Five-Year Plan [15][19] - The report indicates that the bidding volume for wind projects has exceeded expectations, particularly in offshore wind, which is expected to be a highlight for growth in the coming years [5][19] - The report anticipates a structural price increase in the supply chain, particularly in the casting and forging segments, due to tight supply and increasing demand [5][15] Supply Chain and Component Analysis - The demand for large-scale wind turbine components, such as cast and forged shafts, is expected to tighten, with market sizes projected at 6.874 billion CNY for forged shafts and 2.077 billion CNY for cast shafts in 2025-2026 [5][15] - The report emphasizes the importance of production capacity for large blades, as companies with such capabilities are expected to gain significant pricing power [5][15] - The offshore wind market is experiencing a shift towards floating wind farms, with various countries enhancing policies to boost offshore wind installation demand [5][15] Investment Recommendations - The report suggests focusing on companies that are advancing in offshore wind deployment and have a high proportion of overseas customers, including major manufacturers like Mingyang Smart Energy, Goldwind Technology, and Sany Heavy Energy [5][15] - Specific segments to watch include complete turbine manufacturers, casting and forging companies, and those involved in the supply of cables and transformers [5][15] - The investment strategy emphasizes the potential for structural price increases in the supply chain, particularly in components that are currently in high demand [5][15]

Core Insights - The report indicates that the home appliance industry is under pressure but aims for steady progress, with a focus on the impact of policies such as the old-for-new program [1] 2025 Mid-Year Summary - The home appliance sector has experienced a slight decline in valuation, with the industry index down 3.8% from January 1 to June 23, 2025, underperforming the CSI 300 index by 1.9 percentage points [7][18] - Domestic sales have shown significant improvement, with a year-on-year increase of 30.2% in retail sales of home appliances from January to May 2025, driven by the old-for-new policy [27][28] - The export market has also demonstrated resilience, with a cumulative year-on-year increase of 2.2% in appliance exports from January to May 2025, despite tariff concerns [27][28] 2025 Second Half Outlook - The domestic market is expected to benefit from the continuation of the old-for-new policy, with a total of 300 billion yuan allocated for subsidies in 2025, of which 162 billion yuan has already been utilized [39][40] - The report anticipates that the cost pressures from raw materials will remain manageable, with only copper prices showing a significant increase of 15.5% year-to-date [46][49] - The white goods sector is projected to maintain stable growth, benefiting from the old-for-new policy, with recommended stocks including Midea Group, Gree Electric, and Haier Smart Home [8][10] Long-Term Outlook - The report highlights trends towards diversification, globalization, and smart home technology in the home appliance industry, with a focus on high-end consumer potential and cost-performance considerations [39][43]

Investment Rating - The report maintains a "Buy" rating for key companies in the copper industry, indicating a positive outlook on their performance and potential growth [5]. Core Insights - Global copper mine production growth is nearing a turning point, with significant constraints on new supply due to low capital expenditures and declining ore grades [4][14]. - The report highlights the importance of copper price elasticity, driven by sustained demand from energy and electric vehicle sectors, while supply remains constrained [4]. Summary by Sections Copper Mine Overview - Global copper supply growth is projected at 2.0%, 3.0%, and 1.0% for 2025, 2026, and 2027 respectively, indicating a long-term challenge in increasing production [4][18]. - The report identifies that the main reasons for weak production growth include over a decade of low capital expenditure and limited new projects [4][25]. Key Project Analysis - In 2025, four projects are expected to contribute over 50,000 tons of copper, while five projects may see reductions exceeding 40,000 tons [4][46]. - Notable projects include Oyu Tolgoi, Mopani, Udokan, and Las Bambas for increases, while Grasberg, Batu Hijau, and others are highlighted for potential decreases [4][46]. Regional Analysis - Chile faces production challenges due to declining ore grades and insufficient capital expenditure, while the Democratic Republic of Congo shows high potential for production increases [4][58][77]. - Peru's copper production is expected to stabilize as community relations improve, with Las Bambas projected to reach 36-40 million tons by 2025 [70][72]. Recycled Copper - Domestic recycled copper resources are growing slowly, and a decline in imports is exacerbating supply tightness [4][20]. Smelting - The report anticipates a tightening of copper concentrate supply post-2025, leading to worsening overcapacity in smelting [4][21]. Investment Recommendations - Given the long-term demand for copper in energy and electric vehicles, and the constraints on supply, the report emphasizes the need to focus on copper price elasticity [4][25].

Core Insights - The report emphasizes the importance of AI and the overall positive sentiment in the media industry, highlighting the need to focus on certainty assets and optimistic outlooks for 2025 [2][3]. Game Industry - The game industry has shown significant growth, with a year-on-year increase in revenue of 17% in the first five months of 2025, totaling 1411.06 billion yuan [30]. - Mobile games have particularly thrived, generating 1052.28 billion yuan, reflecting a 20% increase year-on-year [30]. - The report suggests that the competitive landscape is easing, with major companies like Tencent and NetEase reducing their sales expenses significantly in Q1 2025, indicating a potential for improved profitability [32][39]. IP Derivatives - The domestic IP derivatives market is rapidly growing, driven by structural opportunities from consumer transitions, with companies like Pop Mart expanding successfully in international markets [7][30]. - The report highlights the differentiated competition among leading players in various segments of the IP derivatives market [30]. Publishing - The publishing sector is advised to focus on high-dividend and certainty assets, with recommendations for companies that show strong cash dividend capabilities or potential changes in AI/IP business margins [7][30]. Advertising and Marketing - The advertising sector is witnessing resilience in offline media, particularly with companies like Focus Media, which is expected to see improved profitability due to a better competitive landscape [7][30]. - The report notes that AI is likely to enhance the performance of marketing companies, with a focus on basic fundamentals improving as the macro environment stabilizes [7][30]. Film and Television - The film industry is currently facing challenges with a lack of major new releases post-Spring Festival, leading to a low box office outlook for the summer season [7][30]. - There are potential opportunities for bottom-fishing in stocks with favorable odds for summer releases, with recommendations for companies like Maoyan Entertainment and Wanda Film [7][30]. Education - The education sector is experiencing heightened demand for quality training, particularly in K12 education, with a focus on major training institutions that are expected to see high revenue growth [7][30]. - The report mentions the competitive landscape in the public examination sector, where leading companies are maintaining strategic focus and delivering quality products [7][30]. Valuation and Financial Analysis - The report provides a detailed valuation analysis of key companies in the media sector, with recommendations for stocks like Mango Excellent Media and Wanda Film, indicating their potential for growth based on current and projected earnings [8][30].

Investment Rating - The industry investment rating is "Buy" with an expectation of stock performance exceeding the market by more than 10% over the next 12 months [2]. Core Insights - The solid-state battery industrialization is accelerating, with significant future potential. Solid-state batteries are recognized as a core direction for next-generation battery technology, offering disruptive advantages and a clear trend towards industrialization globally [4]. - Technological innovations are driving the rapid industrialization of solid-state batteries. Recent advancements, such as the electrolyte design strategy proposed by CATL, are crucial for practical applications of lithium metal batteries (LMB) [4]. - Leading equipment manufacturers are pivotal in the mass production process of solid-state batteries. The transition from liquid to solid electrolytes enhances energy density and safety, necessitating equipment innovations to achieve higher battery efficiency [4]. - The equipment sector is poised for investment opportunities due to the stringent manufacturing precision required for solid-state batteries, creating a natural moat for core equipment manufacturers [4]. - Continuous attention to industry demand and technological changes is recommended, with a focus on companies like Lead Intelligent, Lianying Laser, and others [4]. Summary by Sections Industry Overview - Solid-state batteries are set to reshape the energy storage and power battery competition landscape due to their safety and energy advantages [4]. Technological Developments - Innovations in manufacturing processes, such as dry processing solutions and integrated equipment for solid-state battery production, are being developed by leading companies [4]. Investment Opportunities - The report suggests that the solid-state battery sector will create a new wave of investment opportunities driven by technological advancements and equipment upgrades [4]. Key Companies to Watch - Companies to monitor include Lead Intelligent, Lianying Laser, Yinghe Technology, and others, which are positioned to benefit from the solid-state battery trend [4].

Investment Rating - The report maintains a "Buy" rating for multiple companies in the pharmaceutical and biotech industry, indicating a positive outlook on their growth potential and market performance [6]. Core Insights - The ASCO conference showcased significant advancements in domestic innovative drugs, highlighting the competitive edge of Chinese pharmaceutical companies in the global market [4][12]. - The report emphasizes the clinical value and market potential of several key drugs presented at ASCO, including promising results from various companies [4][12]. Summary by Relevant Sections Domestic Key Research Overview - BaiLi Tianheng's BL-B01D1 demonstrated a 35.3% confirmed overall response rate (cORR) in patients with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) [18]. - DiZhe Pharmaceutical's DZD6008 achieved over 80% overall response rate (ORR) in heavily treated chronic lymphocytic leukemia (CLL) patients, indicating its potential as a new treatment option [4][12]. - FuHong HanLin's PD-L1 ADC showed excellent performance in immune-resistant squamous NSCLC patients, while HLX22 is expected to redefine first-line treatment for advanced gastric cancer [4][12]. - KeLun BoTai's sac-TMT data confirmed long-term survival benefits in third-line EGFR-mutant NSCLC and first-line triple-negative breast cancer (TNBC) [4][12]. - KangNing JieRui's HER2 bispecific ADC demonstrated comparable efficacy and better safety than existing treatments [4][12]. - MaiWei Biotech's 9MW2821 combined with toripalimab is anticipated to be a strong contender in first-line urothelial carcinoma treatment [4][12]. - SanSheng Pharmaceutical updated data on SSGJ-707 for first-line treatment of wild-type NSCLC, with a significant partnership with Pfizer [4][12]. - XinDa Biotech's IBI363 showed potential in activating "cold" tumors, aiming to become a cornerstone drug in immunotherapy [4][12]. - YaSheng Pharmaceutical's Lisaftoclax achieved positive results in patients resistant to venetoclax, filling a treatment gap in myeloid malignancies [4][12]. - ZhengDa TianQing's "DeFu combination" was selected for LBA, potentially offering a new first-line treatment for PD-L1 positive NSCLC [4][12]. - ZeJing Pharmaceutical and ZaiDing Pharmaceutical presented excellent data on ZG006 and ZL-1310 for late-line SCLC treatment, showcasing the global competitiveness of domestic drugs [4][12].

Investment Rating - The report indicates a positive investment outlook for the short drama industry, highlighting significant growth potential in both domestic and overseas markets [4]. Core Insights - The domestic short drama market in China is projected to reach 686 billion yuan in 2025, with a year-on-year growth of 36% [8]. - Free short dramas are becoming the main growth driver, with a market size expected to grow from 250 billion yuan in 2024 to 350 billion yuan in 2025, marking a 40% increase [8]. - The competition landscape is increasingly concentrated, with leading platforms like Tomato expanding their market share significantly [20]. - The user engagement metrics for the leading short drama app, Hongguo, show a remarkable increase, with MAU reaching 173 million in March 2025, a 220% year-on-year growth [51]. Summary by Sections Domestic Short Drama Market - The market size for short dramas exceeded 500 billion yuan in 2024, with a user penetration rate of nearly 60% [8]. - The free short drama segment is expected to grow by 150% in 2024, while the paid segment remains stable [8]. - The number of brands investing in short dramas has increased significantly, with 348 brands participating in 2024 [15]. Overseas Short Drama Market - The overseas short drama market is in a rapid growth phase, with over 300 apps competing for market share [4]. - Companies like Zhongwen Online maintain a leading position in overseas short drama layouts [20]. AI and Short Dramas - AI models are continuously evolving, aiding in the production of short dramas, although commercial viability remains weak [23]. - The application of AI in animation short dramas is accelerating, contributing to cost reduction and efficiency [25]. Competitive Landscape - The competitive dynamics are shifting towards a head-to-head concentration, with Tomato leading the market [20]. - Hongguo's user engagement metrics are significantly higher than those of traditional long video platforms, indicating a shift in viewer preferences [51]. User Engagement and Content Production - The average daily usage time for users on Hongguo has reached 19.36 hours per month, surpassing that of long video platforms [51]. - The number of new short dramas being produced is steadily increasing, with a peak of 5,849 new dramas launched in February 2025 [33]. Brand Investment and Advertising - The advertising investment in short dramas has seen a substantial increase, with beauty and personal care brands dominating the market [15]. - The trend of brand-customized short dramas is becoming mainstream, with significant growth in the number of brand collaborations [15].